Cargando…
Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Thieme Medical and Scientific Publishers Pvt. Ltd.
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590557/ https://www.ncbi.nlm.nih.gov/pubmed/34790325 http://dx.doi.org/10.1055/s-0041-1736164 |
_version_ | 1784598999808868352 |
---|---|
author | Jois, Bhargavi Ananthasivan, Rupa Rawat, Parameswaran R. V. Sudarshan Rakshit, Susmita |
author_facet | Jois, Bhargavi Ananthasivan, Rupa Rawat, Parameswaran R. V. Sudarshan Rakshit, Susmita |
author_sort | Jois, Bhargavi |
collection | PubMed |
description | Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance imaging (MRI) orbit demonstrated bilateral orbital masses with optic nerve encasement. A subsequent 18F-FDG PET/CT scan showed multi-organ disease with involvement of the orbits, pericardium, aorta, pararenal fascia, and appendicular bones. Metabolically active, easily accessible areas were selected for CT-guided biopsy. The biopsy showed sheets of foamy histiocytes with the expression of CD 68 and CD 163 consistent with a diagnosis of Erdheim–Chester disease. The FDG PET/CT played a pivotal role in establishing the diagnosis with the assessment of disease extent and further guided in the targeted biopsy. |
format | Online Article Text |
id | pubmed-8590557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Thieme Medical and Scientific Publishers Pvt. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85905572021-11-16 Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging Jois, Bhargavi Ananthasivan, Rupa Rawat, Parameswaran R. V. Sudarshan Rakshit, Susmita Indian J Radiol Imaging Erdheim–Chester disease is a rare disease with systemic non-Langerhans cell histiocytosis, the diagnosis of which with conventional imaging modalities is challenging. We describe a case of a 73-year-old woman who was referred with a progressive history of bilateral proptosis. The magnetic resonance imaging (MRI) orbit demonstrated bilateral orbital masses with optic nerve encasement. A subsequent 18F-FDG PET/CT scan showed multi-organ disease with involvement of the orbits, pericardium, aorta, pararenal fascia, and appendicular bones. Metabolically active, easily accessible areas were selected for CT-guided biopsy. The biopsy showed sheets of foamy histiocytes with the expression of CD 68 and CD 163 consistent with a diagnosis of Erdheim–Chester disease. The FDG PET/CT played a pivotal role in establishing the diagnosis with the assessment of disease extent and further guided in the targeted biopsy. Thieme Medical and Scientific Publishers Pvt. Ltd. 2021-10-06 /pmc/articles/PMC8590557/ /pubmed/34790325 http://dx.doi.org/10.1055/s-0041-1736164 Text en Indian Radiological Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Jois, Bhargavi Ananthasivan, Rupa Rawat, Parameswaran R. V. Sudarshan Rakshit, Susmita Role of (18) F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging |
title |
Role of
(18)
F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
|
title_full |
Role of
(18)
F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
|
title_fullStr |
Role of
(18)
F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
|
title_full_unstemmed |
Role of
(18)
F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
|
title_short |
Role of
(18)
F-FDG PET/CT in Erdheim–Chester Disease in the Era of Multimodality Imaging
|
title_sort | role of
(18)
f-fdg pet/ct in erdheim–chester disease in the era of multimodality imaging |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8590557/ https://www.ncbi.nlm.nih.gov/pubmed/34790325 http://dx.doi.org/10.1055/s-0041-1736164 |
work_keys_str_mv | AT joisbhargavi roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging AT ananthasivanrupa roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging AT rawatparameswaranrvsudarshan roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging AT rakshitsusmita roleof18ffdgpetctinerdheimchesterdiseaseintheeraofmultimodalityimaging |